Clinical Trial

Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Evaluation of the Excretion of Fosfomycin into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women
Trial Details
NCT Number NCT07618299
Lead Sponsor Meitheal Pharmaceuticals, Inc.
Conditions Healthy Lactating Women
Enrollment 24 participants
Start Date 2026-07
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-01